India Pharma Outlook Team | Monday, 02 November 2026
Weight loss injections draw growing numbers of women who seek faster weight reduction and relief from PMOS symptoms.
Many hope these medicines will solve irregular cycles, metabolic issues, and related concerns in one step.
Experts make clear that the injections can improve weight and metabolic markers yet leave the underlying hormonal condition untouched.
Women who self-medicate overlook the need for personalized assessment of symptoms, reproductive goals, and long-term health.
The rising appeal of weight loss injections reveals a wider misunderstanding of PMOS, where excess weight forms only one piece of a complex hormonal and metabolic picture that demands medical supervision.
PMOS stands as a hormonal and metabolic disorder that disrupts menstrual cycles, ovulation, fertility, and metabolic balance. GLP-1 medicines influence appetite, satiety, and blood sugar control.
Weight reduction, through these injections can improve metabolic health and restore menstrual regularity for some women. Yet those gains do not resolve the root hormonal imbalances.
Dr Hrishikesh Pai, Gynaecologist, IVF Specialist, and Medical Director at Bloom IVF Group, stresses that PMOS involves far more than excess weight. He notes that treatment must target a woman’s specific symptoms and long-term health needs rather than focus exclusively on the number on the weighing scale. Improvements on the scale never equal a cure.
A PMOS diagnosis alone never qualifies every woman for weight loss injections. Doctors must evaluate body weight, blood sugar levels, insulin resistance and related risks before they prescribe.
Dr Kunal Gupta, Consultant Endocrinologist at SPARSH Hospital in Bangalore, explains that these medicines should complement nutrition, physical activity and regular follow-up rather than replace them. Common side effects include nausea, vomiting, constipation, and abdominal discomfort.
Some patients face more serious issues such as gallbladder problems or pancreatitis. Weight regain often follows when treatment stops because appetite-suppressing effects fade. Patients need a long-term weight management plan and ongoing medical monitoring instead of starting or stopping the injections on their own.
Effective care for PMOS looks beyond weight alone. Doctors consider menstrual health, fertility goals, metabolic risks, and psychological well-being. Lifestyle measures, balanced nutrition and regular physical activity form the foundation.
Depending on individual symptoms and goals, clinicians may recommend hormonal contraceptives, metformin, or fertility treatments. Dr Megha Mittal, Senior Consultant in Obstetrics and Gynaecology at Apollo Spectra Hospital Delhi, highlights the need for careful discussion before conception.
Women who plan pregnancy must stop certain GLP-1 medicines, such as semaglutide, at least two months in advance and review contraception with their doctor. Individualized treatment under medical supervision remains essential.
Weight loss injections may support selected PMOS patients when doctors select candidates carefully and provide ongoing oversight. Sustainable management prioritizes overall hormonal, metabolic, and reproductive health rather than rapid weight reduction.
.jpg)
